ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company is headquartered in Yokneam Illit, Israel.
| Revenue (TTM) | $20.92M |
| Gross Profit (TTM) | $7.65M |
| EBITDA | $-17.18M |
| Operating Margin | -123.40% |
| Return on Equity | -209.10% |
| Return on Assets | -35.10% |
| Revenue/Share (TTM) | $15.56 |
| Book Value | $2.26 |
| Price-to-Book | 3.04 |
| Price-to-Sales (TTM) | 0.92 |
| EV/Revenue | 0.79 |
| EV/EBITDA | 1.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -22.10% |
| Shares Outstanding | $2.81M |
| Float | $1.55M |
| % Insiders | 47.60% |
| % Institutions | 0.79% |
Volatility is currently contracting